Association of human cholesteryl ester transfer protein-TaqI polymorphisms with serum HDL cholesterol levels in a normolipemic Japanese rural population

Journal of Epidemiology

Volumn 12, Issue 2, 2002, Pages 77-84

  Chen, Jianguo ^a   Yokoyama, Tetsuji ^a   Saito, Kyoko ^a   Yoshiike, Nobuo ^b   Date, Chigusa ^c   Tanaka, Heizo ^b  

^a Tokyo Medical and Dental University ^*  (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholesteryl ester transfer protein; HDL; Japanese population; Polymorphism

Indexed keywords

APOLIPOPROTEIN; CARRIER PROTEIN; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TAQ POLYMERASE;

ADULT; AGED; ALLELE; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; DRINKING BEHAVIOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; JAPAN; MALE; MIDDLE AGED; RURAL POPULATION; SMOKING; STATISTICAL MODEL;

ADULT; AGED; ALCOHOL DRINKING; ALLELES; APOLIPOPROTEINS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCOPROTEINS; HUMANS; JAPAN; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RURAL POPULATION; SMOKING; TAQ POLYMERASE;

EID: 0036517847     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.12.77     Document Type: Article

References (40)

1. Gordon DJ, Rifkind BM. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med, 1989; 321: 1311-1316.
2. Tall AR. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J Intern Med, 1995; 237: 5-12.
3. Stein O, Stein Y. Atheroprotective mechanisms of HDL. Atherosclerosis, 1999; 144: 285-301.
4. Drayna D, Jarnagin AS, Mclean J et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature, 1987; 327: 632-634.
5. Bruce C, Chouinard RA Jr, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr, 1998; 18: 297-330.
6. Agellon LB, Quinet EM, Gillette TG et al. Organization of the human cholesteryl ester transfer protein gene. Biochemistry, 1990; 29: 1372-1376.
7. Sakai N, Yamashita S, Hirano K et al. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis, 1995; 114: 139-145.
8. Hirano K, Yamashita S, Nakajima N et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol, 1997; 17: 1053-1059.
9. Drayna D, Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res, 1987; 11: 4698.
10. Kondo I, Berg K, Drayna D, Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet, 1989; 35: 49-56.
11. Freeman DJ, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci (Lond), 1990; 79: 575-581.
12. Freeman DJ, Griffin BA, Holmes AP et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb, 1994; 14: 336-344.
13. Hannuksela ML, Liinamaa MJ, Kesaniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis, 1994; 110: 35-44.
14. Fumeron F, Betoulle D, Luc G et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest, 1995; 96: 1664-1671.
15. Kuivenhoven JA, de Knijff P, Boer JMA et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol, 1997; 17: 560-568.
16. Kuivenhoven JA, Jukema JW, Zwinderman AH et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med, 1998; 338: 86-93.
17. Gudnason V, Kakko S, Nicaud V et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. Eur J Clin Invest, 1999; 29: 116-128.
18. Tenkanen H, Koskinen P, Kontula K et al. Polymorphisms of the gene encoding for cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet, 1991; 87: 574-578.
19. Mitchell RJ, Earl L, Williams J, Bisucci T, Gasiamis H. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol, 1994; 66: 13-25.
20. Kessling A, Ouellette S, Bouffard O et al. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones. Am J Hum Genet, 1992; 50: 92-106.
21. Kauma H, Savolainen MJ, Heikkila R et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet, 1996; 97: 156-162.
22. Ordovas JM, Cupples LA, Corella D et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol, 2000; 20: 1323-1329.
23. Corella D, Saiz C, Guillen M et al. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis, 2000; 152: 367-376.
24. Kark JD, Sinnreich R, Leitersdorf E et al. TaqIB CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis, 2000; 151: 509-518.
25. Mendis S, Shepherd J, Packard CJ, Gaffney D. Genetic variation in the cholesteryl ester transfer protein and apolipoprotein A-I genes and its relation to coronary heart disease in a Sri Lankan population. Atherosclerosis, 1990; 83: 21-27.
26. Tanihara S, Ojima T, Nakamura Y et al. Association between health-related knowledge and the awareness of blood pressure readings. Japan Lifestyle Monitoring Study Group J Epidemiol, 1999; 9: 245-253.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502.
28. Baba T, Tanaka H, Date C et al. The standardization of measurement of lipids for epidemiologic study of stroke. Jpn J Hyg, 1983; 38: 606-613.
29. Wilson PW, Paffenbarger RS Jr, Morris JN, Havlik RJ. Assessment methods for physical activity and physical fitness in population studies: report of a NHLBI workshop. Am Heart J, 1986; 111: 1177-1192.
30. Gart JJ, Nam JA. A score test for the possible presence of recessive alleles in generalized ABO-like genetic systems. Biometrics, 1984; 40: 887-894.
31. Elston RC, Forthofer R. Testing for Hardy-Weinberg equilibrium in small samples. Biometrics, 1977; 33: 536-542.
32. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity, 1974; 33: 229-239.
33. SAS Institute Inc. SAS/STAT User's Guide, Version 6, Fourth Edition, Volume 2. Cary, NC: SAS Institute Inc., 1989: 846.
34. Anonymous. NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. JAMA, 1993; 269: 505-510.
35. Traut TW. Do exons code for structural or functional units in proteins? Proc Natl Acad Sci USA, 1988; 85: 2944-2948.
36. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol, 2000; 20: 507-515.
37. Davis CE, Gordon D, LaRosa J, Wood PDS, Halperin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations. The lipid research clinics program prevalence study. Circulation, 1980; 62 (Suppl IV): 24-30.
38. Heiss G, Johnson NJ, Reiland S, Davis CE, Tyroler HA. The epidemiology of plasma high-density lipoprotein cholesterol levels. The lipid research clinics program prevalence study. Summary. Circulation, 1980; 62 (Suppl IV): 116-136.
39. Salonen JT, Happonen P, Salonen R et al. Interdependence of association of physical activity, smoking, and alcohol and coffee consumption with serum high-density lipoprotein and non-high-density lipoprotein cholesterol-a population study in eastern Finland. Prev Med, 1987; 16: 647-658.
40. Silliman K, Tall AR, Kretchmer N, Forte TM. Unusual high-density lipoprotein subclass distribution during late pregnancy. Metabolism, 1993; 42: 1592-1599.